A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
Titel:
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
Auteur:
Koreth, John Kim, Haesook T. Lange, Paulina B. Bindra, Bhavjot Reynolds, Carol G. Chammas, Marie J. Armand, Philippe Cutler, Corey S. Ho, Vincent T. Glotzbecker, Brett Nikiforow, Sarah Ritz, Jerome Blazar, Bruce R. Soiffer, Robert J. Antin, Joseph H. Alyea III, Edwin P.
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 21 (2015) nr. 11 pagina's 7 p.
Jaar:
2015
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation